United States · FDA National Drug Code directory
Lorazepam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-0329_1577a3f6-8289-4621-a0e5-9d69bc6218d3
- Product NDC
- 71335-0329
- Form
- TABLET
- Composition / generic term
- Lorazepam
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230516
- Source listing expiry
- 20261231
Source-listed ingredients
- LORAZEPAM — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71335-0329-1) · 71335-0329-1
- 10 TABLET in 1 BOTTLE (71335-0329-2) · 71335-0329-2
- 60 TABLET in 1 BOTTLE (71335-0329-3) · 71335-0329-3
- 90 TABLET in 1 BOTTLE (71335-0329-4) · 71335-0329-4
- 15 TABLET in 1 BOTTLE (71335-0329-5) · 71335-0329-5
- 100 TABLET in 1 BOTTLE (71335-0329-6) · 71335-0329-6
- 120 TABLET in 1 BOTTLE (71335-0329-7) · 71335-0329-7
- 2 TABLET in 1 BOTTLE (71335-0329-8) · 71335-0329-8
- 5 TABLET in 1 BOTTLE (71335-0329-9) · 71335-0329-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →